Search

everythinglearnresearchcommunity

for

Search:↓

PRP injection for hair growth can cause reversible vision loss due to inflammatory optic neuropathy.

Sildenafil may help with some skin conditions and hair growth, but more research is needed.

Telogen effluvium is common after symptomatic COVID-19, especially in young females, and may be linked to nutritional deficiencies.

COVID-19 vaccination may be linked to MIS-C in children, highlighting the need for quick diagnosis and treatment.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Both PRP and MZT treatments can significantly improve hair growth in patients with androgenetic alopecia.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

About 61% of women who had COVID-19 experienced hair loss afterward.

Some COVID-19 pneumonia patients in Veracruz, Mexico, had skin issues, with reversible hair loss linked to disease severity.

Anticoagulant therapy may cause hair loss, especially in women, and stopping the medication can lead to hair regrowth.

PDRN is effective and safe for healing wounds and skin issues.

Enteric hyperoxaluria can cause severe kidney failure after bowel surgery.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

The new formulation greatly improved quercetin absorption in rats.

Platelet-rich fibrin shows promise for treating oral lesions but needs more research.

A woman lost all her hair after overdosing on divalproex, but it grew back while still on the medication.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

Oncology specialists are disappointed by the discontinuation of the effective lymphoma treatment Bexxar.

The medication cyproterone acetate/ethinylestradiol is usually prescribed correctly for acne after other treatments don't work.

FOLFOX6 chemotherapy effectively reduces VEGF levels and improves quality of life in advanced colorectal cancer patients.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Prostaglandin E2 affects human platelet activity in complex ways that could lead to personalized heart disease treatments.

Cyproterone acetate and ethinylestradiol effectively reduce hirsutism and acne in women.

Anti-phospholipid antibodies in SLE can cause thrombosis and bone necrosis.

Eclipta alba phytosomes improve bioavailability and therapeutic effects.

Etanercept may not prevent alopecia areata from coming back.